MORGAN STANLEY PLC/CALL/ZOETIS/260/0.1/20.12.24 | Market Closed - Börse Stuttgart 15:21:27 2024-05-23 EDT | ||
| 0.163 EUR | +0.62% |
|
| 1 month | +12.41% | ||
| 3 months | -58.21% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ZOETIS INC.
Latest news about ZOETIS INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-23 | 0.163 | +0.62% |
| 24-05-22 | 0.162 | +1.25% |
| 24-05-21 | 0.16 | -4.19% |
| 24-05-20 | 0.167 | +1.83% |
| 24-05-17 | 0.164 | -4.65% |
Delayed Quote Börse Stuttgart
Last update May 23, 2024 at 03:21 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | ZOETIS INC. |
| Issuer | Morgan Stanley |
| WKN | MB3SPA |
| ISIN | DE000MB3SPA6 |
| Date issued | 2023-02-17 |
| Strike | 260 $ |
| Maturity | 2024-12-20 (211 Days) |
| Parity | 10 : 1 |
| Emission price | 0.92 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.71 € |
|---|---|
| Lowest since issue | 0.129 € |
| Spread | 0.01 € |
| Spread % | 5.71% |
Company Profile
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows:
- pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%);
- livestock (34.5%): cattle (51.6% of sales), swine (20.2%), poultry (17.1%), fish (7.6%) and other (3.5%);
- other (1.1%).
Net sales break down by family of products into parasiticides (23%), vaccines (21.3%), dermatological products (16.4%), anti-infectives (13.4%), medical food additives (4.5%), diagnostic products (4.4%) and other (17%).
At the end of 2022, the group has 29 production sites worldwide.
The United States accounts for 53.4% of net sales.
Sector
-
Consensus: Zoetis Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
170.9
USD
Average target price
211.2
USD
Spread / Average Target
+23.58%
- Stock Market
- Warrants
- Warrant
